Can-Fite BioPharma Ltd. (CANF)
AMEX: CANF
· Real-Time Price · USD
1.13
0.06 (5.61%)
At close: Jun 16, 2025, 12:37 PM
13F Institute Ownership
Total Institutes of 13 in Can-Fite BioPharma expanded their positions with an increase of 2 investors compared to the previous quarter. A reduction of 639.81K shares, as total invested capital declined by $1.33M with ownership percentage dropping from 10.35% to 1.58%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 0.45% | 32.51K | -35.82% | 52.83K | < 0.01% |
| Rhumbline Advisers | 0.37% | 26.88K | +58.63% | 43.67K | < 0.01% |
| BNP Paribas Arbitrage, Snc | 0.35% | 25.18K | +100.00% | 40.93K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.